A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer ...

The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...

A new strategy strengthens the bond between the T cell and a target tumor cell, improving the cytotoxic function of the T cell.

The powerful gene-editing technique CRISPR–Cas9 might offer a way to make safer, more effective cancer-fighting immune cells ...

UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...

Immunotherapy has transformed cancer care, offering a way to harness the body’s own immune system to fight tumors. But even with these advances, many patients still don’t respond. One major barrier to ...

This new type of immunotherapy shows promise for treating different cancers including prostate cancer, leukaemia and lung ...

New research shows lymph nodes aren’t just cancer bystanders, they’re the command centers fueling immune attacks. Surgically removing them along with tumors may weaken treatment, while preserving them ...

Add Yahoo as a preferred source to see more of our stories on Google. Regulatory T cells (red) interact with other immune cells (blue) and modulate immune responses. National Institute of Allergy and ...

Since its introduction in the late 1980s, HIV antiretroviral therapy (ART) has saved millions of lives by transforming HIV from a fatal disease into a chronic, manageable condition. Despite these ...